Results 201 to 210 of about 499,895 (395)

Prognostic value of lipid parameters among patients with heart failure: A systematic review and meta‐analysis

ESC Heart Failure, EarlyView.
Abstract Aims We sought to evaluate the prognostic value of different lipid parameters in patients with heart failure (HF). Methods and Results Electronic databases including MEDLINE, Embase, CENTRAL, and Web of Science were searched to identify studies that reported the association of any of the four lipid parameters [total cholesterol (TC), high ...
Ahmed Sayed, Hesham Afify, Malak Munir, Ibrahim ElGarhy, Omar Shazly, Mohamed ElRefaei, Saeed Ahmed, Ahmed Mazen Amin, Omar Chikh Amine, Islam Y. Elgendy   +9 more
wiley   +1 more source

A case of idiopathic hypertrophic obstructive cardiomyopathy with an audible pseudoejection sound on auscultation.

, 1984
Toshiaki Shiomi, Tadashi Kobayashi, Hideki Tachibana, Kenji Ebihara, Manabu Adachi, Yasushi Wakida, Koya Mizutani, Tsutomu Watanabe   +7 more
openalex   +2 more sources

Nonsurgical Septal Reduction Therapy for Hypertrophic Obstructive Cardiomyopathy: One‐Year Follow‐up [PDF]

, 2000
David Tepper
openalex   +1 more source

The effects of early exercise on cardiovascular biomarkers in patients with congestive heart failure

ESC Heart Failure, EarlyView.
Abstract Background Exercise training improves functional outcomes in chronic heart failure (HF), but the effects of early in‐hospital physical activity on cardiovascular biomarkers and prognosis in acute congestive heart failure (AHF) patients remain unclear.
Yanxiang Sun, Xuansheng Huang, Bing Hu, Zidi Wu, Yanchun Zhang, Yong Yuan, Li Feng   +6 more
wiley   +1 more source

Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and beta-adrenergic blocker therapy.

, 1992
Lameh Fananapazir, R O Cannon, Dominique Tripodi, Julio A. Panza   +3 more
openalex   +1 more source

Pacing in obstructive hypertrophic cardiomyopathy [PDF]

, 2001
F. Gadler
openalex   +1 more source

A two‐phase approach to identifying HFpEF in heart failure patients: Risk score evaluation and decision tree development

ESC Heart Failure, EarlyView.
Abstract Aims Heart failure (HF) with preserved ejection fraction (HFpEF) poses significant diagnostic challenges due to its complex aetiology and overlapping symptoms with other HF types. The heterogeneity of HFpEF, compounded by frequent comorbidities, complicates diagnosis. This study aimed to enhance HFpEF prediction through a two‐phase approach: a
Izabella Uchmanowicz, Magdalena Lisiak, Piotr Ponikowski, Ewa A. Jankowska, Andrzej Mysiak, Marta Wleklik   +5 more
wiley   +1 more source

Paradoxic septal motion during PEEP ventilation [PDF]

, 1989
Daum, S., Forst, Helmuth, Menger, M., Messmer, Konrad, Racenberg, J., Zwißler, Bernhard   +5 more
core   +1 more source

Decreased Expression of Tumor Necrosis Factor-α and Regression of Hypertrophy After Nonsurgical Septal Reduction Therapy for Patients With Hypertrophic Obstructive Cardiomyopathy [PDF]

, 2001
Sherif F. Nagueh, Sonny J. Stetson, Nasser Lakkis, Donna Killip, Alex Perez-Verdia, Mark L. Entman, William H. Spencer, Guillermo Torre‐Amione   +7 more
openalex   +1 more source

Lower left ventricular ejection time in MYBPC3 variant carriers with overt or subclinical hypertrophic cardiomyopathy

ESC Heart Failure, EarlyView.
Abstract Aims Hypertrophic cardiomyopathy (HCM) is an inherited cardiomyopathy often caused by pathogenic variants in MYBPC3 and MYH7, encoding myosin‐binding protein C3 and myosin heavy chain 7, respectively. These variants can cause increased actin–myosin crossbridge cycling, resulting in ventricular hypercontractility, but mice lacking Mybpc3 ...
Isabell Yan, Zoe Möhring, Daniel Reichart, Fanny Kortüm, Julia Münch, Rixa Woitschach, Paulus Kirchhof, Lucie Carrier, Carolyn Y. Ho, Thomas Eschenhagen, Monica Patten   +10 more
wiley   +1 more source